Warren Huff | Chief Executive Officer |
Manmeet Soni | President |
Colin Meyer | Chief Innovation Officer |
Seemi Khan | Chief Medical officer |
Dawn Bir | Chief Commercial Officer |
Yigal Nochomovitz | Citigroup |
Madhu Kumar | Goldman Sachs |
Joseph Schwartz | SVB Leerink |
Thank you for standing by and welcome to Reata Pharmaceuticals First Quarter 2022 Financial Results and Update on Development Programs Conference Call. An audio recording of today's webcast will be available shortly after the call in the Investors section of Reata's website at reatapharma.com.
Before the company proceeds with its remarks, please note that forward-looking statements disclosure in the company's press release. There are many factors that could cause results to differ from expectations, including those noted in the company’s SEC filings. On today's conference call non-GAAP financial measures will be used to help investors understand the business performance.